Topic Listing for Neurogen

Accounts Payable Accrued Expenses Additional Deposit
Additional Information Find Administration
Affiliate Aggregated Option Exercises Last Year-end Values
Agreement Agreements Instruments
Alan Hutchison Amendment
Amendment Suspension Termination Plan Amendments Consent Holders
Amendments Without Consent Holders American Title Insurance
Annual Meeting Attendance Annual Meeting Stockholders
Annual Report Pursuant Securities Exchange Act 1934 2004 Antagonist Program
Aplindore Cvr Payment Amount Aplindore Cvr Payment Date
Aplindore Cvr Payment Event Aplindore Cvr Register
Aplindore Cvr Registrar Aplindore Cvrs
Aplindore Expense Reserve Balance Aplindore Sale
Applicable Laws Approval Amendments Plan
Approvals8221 Assignee
Assignment Termination Assignments
Assumed Contracts Attorneys8217 Fees Costs
Audit Committee Audit Committee Report
Audit Fees Other Authorizations
Available Information Aventis
Awards Plan Background Drug Discovery Industry
Beneficial Ownership Reporting Compliance Benefit Plans
Benefits Agreement Board Recommendation
Board Resolution Branford 2008
Branford 2008 8212 Branford 20088212
Buildings Business
Buy-in Buyer Consolidate Etc
Captions Cash Marketable Securities
Cautionary Statement Purposes Safe Harbor Provisions Private Securities Certain Duties Responsibilities
Certain Relationships Related Transactions Certain Rights Agent
Certificate Designations Certificate Registration Transfer Change Address
Certification Pursuant 302 Sarbanes-oxley Act 2002 Certification Pursuant 906 Sarbanes-oxley Act 2002
Certification Pursuant 906 Sarbanes-oxley Act 2002 Usc 1350 Change Control
Changes Internal Control Over Financial Reporting Closing
Closing Date Closing Purchase Price
Code Code Ethics
Collaboration Costs Collaborative Research Agreements
Commissioner Dep8221 Commitments Contingencies
Committees Board Directors Common Stock
Compensation Committee Compensation Committee Interlocks Insider Participation
Competitive Environment Components Neurogens Discovery Development Platform
Comprehensive Loss Confidentiality
Consent Independent Registered Public Accounting Firm Consolidated Financial Statements
Contingent Value Rights Agreement Dated 8226 2009 8220 Contractual Obligations
Controls Procedures Corporate Governance
Costs Prorations Counterparts
Critical Accounting Policies Cvr Payment Amount
Cvr Payment Date Cvr Payment Event
Cvr Register Cvr Registrar
Cvrs Damage Destruction Condemnation
Debt Arrangements Defaults Senior Securities
Definitions Deposit
Depression Anxiety Program Crf-1 Receptor Antagonist Director Compensation
Directors Executive Officers Registrant Disclosure Controls Procedures
Dissenters Right Appraisal Due Diligence
Easement Agreement Effect Amendments
Effect Headings Election Directors
Eligibility Employees
Entire Agreement Environmental Easement
Environmental Escrow Agreement Environmental Indemnification
Environmental Indemnity Environmental Laws
Equity Compensation Plan Information Equity Offering
Erisa Escrow Agent
Escrow Agent8217s Fee Escrow Funds
Escrow Funds8221 Escrow Provisions
Eurogen Corporation Evaluation Investments Other-than-temporary Impairment
Except Per Share Data Exchange
Exchange Act Exchange Shares
Execution Amendments Executive Compensation
Executive Officers Federal Tax Consequences Awards Options
Final Verification8221 Financial Statements Exhibits
Financing Activities Forma Lease
Forward-looking Statements Gaap
Gender Number General
Governance Committee Governing Law
Government Regulation Governmental Authority
Governmental Licenses Grantee8221
Grantor8221 Grants Subject Stockholder Approval
Health Care Laws Holder
Hsr Act Immediate Release
Improvements Income Taxes
Independence Board Directors Independent Registered Public Accountants
Initial Deposit Insomnia Program Gaba Partial Agonist Adipiplon Formerly Ng2-73
Insomnia Program Unique Gaba Modulation Profile Intellectual Property
Internal Control Over Financial Reporting Issuance Aplindore Cvrs Appointment Rights Agent
Issuance Cvrs Appointment Rights Agent Issuance Merck Cvrs Appointment Rights Agent
Issuance Real Estate Cvrs Appointment Rights Agent James Cassella
Joint Several Liability Jurisdiction Service Process
Kenneth Shaw Legal Holidays
Legal Proceedings Licensing Event
Licensing Option Event Licensing Option Payment Amount
Licensing Payment List Holders
Loans Payable Long-lived Assets
Majority Purchasers Managements Annual Report Internal Control Over Financial Reporting
Manufacturing Market Registrants Common Equity Related Stockholder Matters Issuer
Marketable Securities Material Adverse Effect
Material Amount Materials
Meetings Board Directors Merck
Merck Cvr Payment Amount Merck Cvr Payment Date
Merck Cvr Payment Event Merck Cvr Register
Merck Cvr Registrar Merck Cvrs
Merck Vr1 Agreement Merger
Money Laundering Laws Negotiation Arbitration
Net Loss Per Common Share Neurogen
Neurogen Collaborations Neurogen Corp Buildings
Neurogen Corp Land Neurogen Corporation
Neurogen Corporation 2001 Stock Option Plan Neurogen Corporation Certification Pursuant 906 Sarbanes-oxley Act 2002
Neurogen Corporation Nasdaq Nrgn Neurogen Corporation Notes Consolidated Financial Statements 2005
Neurogen Corporation Receives Notice Nasdaq Regarding Listing Securities Neurogen Drug Development Programs
Neurogen Llc Building Next Annual Meeting Stockholders
Nominee Nontransferable
Notice Annual Meeting Stockholders Notice Holders
Notices Notices Rights Agent Buyer
Now Therefore Number Shares
Obesity Diabetes Program Mch1 Receptor Antagonist Officer Compensation
Officer8217s Certificate Operating Costs
Organization Other Information Exhibits 311 Certification Pursuant 302 Sarbanes-oxley
Other Matters Outside Date
Outside Date8221 Overview
Pain Management Program Vr1 Receptor Antagonist Part Other Information
Party Purchaser Patents Proprietary Technology
Payment Aplindore Cvr Amount Payment Cvr Amount
Payment Merck Cvr Amount Payment Procedures
Payment Real Estate Cvr Amount Pending Default
Per Unit Purchase Price Performance Graph
Permitted Exceptions Permitted Transfer
Person Pfizer
Phase Vr1 Trial Initiation Payment Event Plans
Postage-prepaid Mailed United States Preferred Stock
Price Payment Principal Accounting Fees Services
Principal Stockholders Prior Grants Options
Properties Property
Proposals Proprietary Information
Proxy Statement Proxy Voted Directed Contrary Direction Included Proposals
Purchase Agreement8221 Purchase Price
Purchaser Purchaser Parties
Purchaser Shall Not Conduct Allow Physically Intrusive Testing Purchaser8217s Indemnity Obligations
Purchaser8217s Inspections Purchasers
Purpose Quantitative Qualitative Disclosures Market Risk
Real Estate Cvr Payment Amount Real Estate Cvr Payment Date
Real Estate Cvr Payment Event Real Estate Cvr Register
Real Estate Cvr Registrar Real Estate Cvrs
Real Estate Sale Recently Issued Accounting Pronouncements
Recitals Defined Terms Record Date Share Ownership
Recordation Reduction Force
Reference Agreement Registration Rights Agreement
Registration Statement Regulation
Related Parties Repayment Event
Report Compensation Committee Board Directors Report Independent Registered Public Accounting Firm
Representations Warranties Research Development Costs
Research Development Expenses Resignation Removal Appointment Successor
Responsibilities Restricted Stock
Results Operations Revenue Recognition
Revocability Proxies Rights Agent
Rights Agent Fee Rights Agreement
Safe Harbor Statement Sale Event
Sale Option Event Sale Option Payment Amount
Sale Payment Amount Sales Marketing
Schedule Schedule 14a
Sec Documents Securities
Securities Act Security Ownership Certain Beneficial Owners Management
Security Ownership Certain Beneficial Owners Management Related Stockholder Selected Financial Data
Seller Seller8217s Liens
Severability Severability Clause
Shares Signatures
Sole Discretion Decision Making Authority Fiduciary Duty Statement Policy
Stephen Davis Stock Options Restricted
Stock-based Compensation Stockholder Communications Board Directors
Stockholders Meeting Stockholders Meeting Deadline
Stockholders Neurogen Corporation Sub
Submission Matters Vote Security Holders Subsequent Events
Subsidiary Successor Substituted
Successors Assigns Summary Significant Accounting Policies
Supplemental Cash Flow Information Table Contents
Tax Benefits Taxes
Tenant Receivables Termination
Terms Conditions Certain Employment Severance Agreements William Koster Thomas Pitler
Title Transaction Agreements
Transfer Act Transfer Act Compliance
Transfer Act8221 Transfer Agent
United States Units
Voting Dividends Interest Equity Ownership Buyer Voting Proxy
Voting Solicitation Voting Via Internet Telephone
Vr1 Program Rights Vr1 Program Sales Payment Amount
Vr1 Program Sales Payment Event Waiver
Warrant Shares Warrants
William Koster Witness Whereof
Witness Whereof Each Parties Caused Agreement Executed Behalf 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki